CN108977510A - Detect the method and application of CLC gene expression amount in nasal cavity cast-off cells - Google Patents
Detect the method and application of CLC gene expression amount in nasal cavity cast-off cells Download PDFInfo
- Publication number
- CN108977510A CN108977510A CN201810719334.2A CN201810719334A CN108977510A CN 108977510 A CN108977510 A CN 108977510A CN 201810719334 A CN201810719334 A CN 201810719334A CN 108977510 A CN108977510 A CN 108977510A
- Authority
- CN
- China
- Prior art keywords
- rna
- clc
- nasal cavity
- cells
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention proposes a kind of method and application for detecting the non-diagnostic purpose of CLC gene expression amount in nasal cavity cast-off cells, the following steps are included: extracting RNA from nasal cavity cast-off cells, it is cDNA by total serum IgE reverse transcription, the specific primer of CLC gene and reference gene specific primer and reference gene that CLC gene is respectively adopted in cDNA is carried out by real-time fluorescence quantitative PCR amplification using quantitative polyase chain reaction, testing result based on amplified production calculates CLC gene expression amount.The method of the present invention, using the CLC gene of Effective selection as biomarker, detection method to its gene expression amount is provided, realize the calculating to CLC gene expression amount in nasal cavity cast-off cells, CLC gene expression amount can be effectively obtained, and the method provided is simple and fast, sensibility is high, it is reproducible, it is suitable for wide popularization and application.
Description
Technical field
The invention belongs to CLC gene expressions in biomedicine technical field more particularly to a kind of detection nasal cavity cast-off cells
The method of amount.
Background technique
Chronic nasosinusitis is with nasal polyp (Chronic rhinosinusitis with nasal polyps, CRSwNP)
The chronic inflammation of sinus mucosa, the visible nasal cavity of physical examination or middle nasal meatus polyp are formed.CRSwNP common sympton is stifled nose, runny nose or nose
Tears refluence, hyposphresia, the bored swollen sense of face or feeling of stress, duration are more than 12 weeks.Illness rate is about 0.5-4%, CRSwNP
It is often accompanied by asthma and allergic rhinitis, has been reported that 7% asthmatic patient suffers from CRSwNP, and the CRSwNP of 26-48% is with heavy breathing
Asthma.CRSwNP pathogenesis is also uncertain at present, and mucosal epithelial cells destroy, host immune system is unbalance and pathogenic microorganism enters
Invade the main reason for may be its morbidity.The main therapeutic modality of CRSwNP is operation and drug therapy.But studies have shown that even if
By the drug or operative treatment of specification, chronic nasosinusitis is still up to 56% with the recurrence rate of nasal polyp, and it is raw to seriously affect patient
Bioplasm amount, while bringing high medical to pay, but clinical shortage radical treatment method, thus become nasology research field
Emphasis.
Degree according to eosinophils can divide CRSwNP for eosinophil type (Eosinophilic
CRSwNP, ECRSwNP) and Non eosinophilic granulocyte type (Noneosinophilic CRSwNP, nonECRSwNP), the two is faced
Bed performance, medication and prognosis are different, and the clinical symptoms of eosinophil type are heavier, with nose is stifled and hyposphresia based on, it is more
It is associated with asthma, Postoperative recurrent rate is higher.Eosinophils degree and relapse are the closest in human nasal polyps tissues,
When the cell percentages are more than 27% in tissue, risk of recurrence is more than 90%.Eosinophil type polyp is to sugared cortical hormone
The susceptibility of plain class drug is significantly higher than Non eosinophilic granulocyte type.Non eosinophilic granulocyte type clinical symptoms are generally relatively light, and
The probability for merging asthma is smaller, and airway inflammation is lighter, and Postoperative recurrent rate is low compared with eosinophil type, to macrolides medicine
Object therapeutic response is good.Western countries are mainly shown as TH2 inflammatory reaction based on eosinophil type, and the acidophilus in China
Property granulocyte type and Non eosinophilic granulocyte type ratio account for about half, and Non eosinophilic granulocyte type is mainly shown as TH1/TH17
Based on inflammatory reaction.In conclusion eosinophil type and Non eosinophilic granulocyte type are in immunopathogenesis type, clinical condition
There are significantly different for shape, drug therapy reaction and prognosis.Different chronic nasosinusitis treat plan with inflammation/pathological of nasal polyp
It is slightly different.So the identification to chronic nasosinusitis with the pathological of nasal polyp is particularly important.
The judgement of two kinds of hypotypes is lacked non-invasive mainly according to histopathology specimen staining after bronchia mucosal biopsy at present
Biological markers are used for antidiastole.After patient obtains polyp sample under nasal endoscopes, the Pathologic specimens such as progress paraffin is fixed
Conventional treatment, then carry out haematoxylin Yihong dyeing, followed by the inflammatory cell of ultramicroscopic observation tissue infiltration
(main inflammatory cell includes eosinophil, neutrophil leucocyte, lymphocyte, thick liquid cell) infiltrates number, carries out cell point
Type.The shortcomings that bronchia mucosal pathological biopsy is as follows: 1. be invasive inspection: increasing the infection risk of patient, is not suitable for being immunized
Power lower crowd such as children, the elderly etc.;Nasal bleeding when materials often causes patient frightened and worry.2. being difficult to obtain disease
The real-time dynamic-change information of disease: pathological biopsy cannot be carried out to healing stage mucous membrane after surgery.But clinical data shows chronic nose
Sinusitis can be lapsed to the pathological classification of nasal polyp with drug therapy, operative treatment etc., can not with the pathological biopsy result before treatment
Represent the feature of whole disease durations.3. time-consuming and increase medical treatment cost, general to pathological examination is obtained from tissue samples are obtained
3-4 working day.Due to can not obtain the same day or next day as a result, the additional transportation expenses of generations such as nonlocal patient sees a doctor, hotel expense,
Registration fee increases medical treatment cost.4. the inflammatory cell quantity that different pathologists counts has can there are certain human error
Can be different, influence the judgement of polyp parting.5. tissue pathological slice relatively limits to, it can only reflect the sample inflammation shape of slice position
State cannot reflect the overall picture of tissue, be likely to result in mistaken diagnosis.6. every piece requires Pathologis artificial counting, it is difficult to
Batch operation.
In recent years the real-time fluorescence quantitative PCR risen compensates for the deficiency of above-mentioned technology.This method is in PCR reaction system
Fluorophor is added, using the entire PCR process of the accumulation real-time monitoring of fluorescence signal, finally according to fluorescence signal to surveyed DNA
Sample carries out quantitative analysis, and this method is easy to operate, and sensibility is high, and reproducible and result accuracy is high.However the prior art
In not yet disclose the method for CLC gene expression amount in detection nasal cavity cast-off cells be effectively provided, it is de- preferably to get nasal cavity
Fall intracellular CLC gene content situation.
Summary of the invention
The present invention for the above technical issues, proposes a kind of side for detecting CLC gene expression amount in nasal cavity cast-off cells
Method.
In order to achieve the above object, the technical solution adopted by the present invention are as follows:
A method of CLC gene expression amount in detection nasal cavity cast-off cells, comprising the following steps: from nasal cavity cast-off cells
Total serum IgE reverse transcription is cDNA, using quantitative polyase chain reaction by the CLC gene and reference gene in cDNA by middle extraction RNA
The specific primer of specific primer and reference gene that CLC gene is respectively adopted carries out real-time fluorescence quantitative PCR amplification, is based on
The testing result of amplified production calculates CLC gene expression amount.
Preferably, the upstream primer of CLC gene is as shown in SEQIDNO:2, the downstream primer of CLC gene such as SEQIDNO:
Shown in 3.
Preferably, the reference gene is GAPDH, the upstream primer of the reference gene is as shown in SEQIDNO:4, institute
Downstream primer is stated as shown in SEQIDNO:5.
Preferably, the nasal cavity cast-off cells are obtained using hairbrush in nasal polyp surface, and it will acquire nasal cavity and fall off carefully
Hairbrush after born of the same parents is placed in cell pyrolysis liquid to be saved in 4 DEG C or less.
Preferably, the method for extracting RNA from nasal cavity cast-off cells, including two methods, wherein first method packet
Include following steps:
Step 1: the nasal cavity cast-off cells being dissolved in 100~2000 μ L cell pyrolysis liquids, and are added in equal volume
Ethyl alcohol is added after mixing into RNA purification column, after centrifugal treating, removes the filtrate in collecting pipe, the RNA is purified
Column is placed in collecting pipe;
Step 2: the first buffer of 300 μ of μ L~700 L being added into the RNA purification column obtained in step 1, is centrifuged
After processing, the first filtrate is removed;Continue that 400 μ of μ L~800 the second buffers of L are added to the RNA purification column, after centrifugal treating,
The second filtrate is removed, takes RNA purification column through affording RNA.
Preferably, the method for extracting RNA from nasal cavity cast-off cells, further comprising the steps of: to described in removing
10~100 μ L DNA enzymatic reaction solutions are added in RNA purification column after second filtrate, and after stewing process, 300 μ of μ L~700 are added
Second buffer described in L after centrifugal treating, removes third filtrate, takes RNA purification column after eluting using spectrophotometer measurement
RNA purity, obtains RNA;
The preparation method of the DNA enzymatic reaction solution goes RNA enzyme the following steps are included: take DNA enzymatic buffer, recombinant dnase
Distilled water be mixed to get DNA enzymatic reaction solution.It is preferred that the preparation method of the DNA enzymatic reaction solution is the following steps are included: take 5 μ L
10 × DNA enzymatic buffer, 4 μ L recombinant dnases, 41 μ L go the distilled water of RNA enzyme to be mixed to get DNA enzymatic reaction solution.
Preferably, genome content is lower or when material initial amount is less when carrying out RNA extraction, it is described de- from nasal cavity
The method for extracting RNA is fallen in cell, and further comprising the steps of: in the step 1, the nasal cavity cast-off cells are dissolved in cell and split
It is first added after in solution liquid into genomic DNA adsorption column and takes filtrate, then isometric ethyl alcohol is added into the filtrate.
Preferably, in order to obtain the RNA of higher concentration, the method that RNA is extracted from nasal cavity cast-off cells is also wrapped
It includes following steps: taking RNA purification column to be eluted that the distilled water for removing RNA hydrolase or pyrocarbonic acid diethyl ester processing water, room is added
After temperature is stood, RNA is obtained using spectrophotometer measurement RNA purity through centrifugal treating, the elution RNA purification column.
Wherein step 1 can be crushed rapidly nasal cavity cast-off cells using cell pyrolysis liquid and nasal cavity cast-off cells is inhibited to discharge
The substance of nuclease out;Using genomic DNA adsorption column for removing genomic DNA;RNA purification column in step 2 is used for
It is enriched with RNA;Wherein collecting pipe be used for collects remove genomic DNA after solution, for remove be adsorbed with RNA purification column it is miscellaneous
First buffer of matter, the second buffer for removing impurity and salinity in RNA solution.
Specifically, the first method for extracting RNA from nasal cavity cast-off cells, comprising the following steps:
Step 1: the nasal cavity cast-off cells being dissolved in 300 μ L cell pyrolysis liquids, and 70% isometric second is added
Solution is uniformly mixed by alcohol using liquid-transfering gun;Mixed liquor is added into RNA purification column immediately, 12000 revs/min, is centrifuged
1min removes filtrate, the RNA purification column is placed in 2mL collecting pipe;
Step 2: it is added the first buffer of 500 μ L into the RNA purification column obtained in step 1,12000 revs/min
Clock is centrifuged 30s, removes the first filtrate;Continue that 600 the second buffers of μ L are added to the RNA purification column, 12000 revs/min,
It is centrifuged 30s, removes the second filtrate;
Step 3: taking 5 μ 10 × DNA enzymatic of L buffers, 4 μ L recombinant dnases, 41 μ L go the distilled water of RNA enzyme through mixing
To DNA enzymatic reaction solution, 50 μ L DNA enzymatic reaction solutions are added into the RNA purification column after removing second filtrate, are stored at room temperature
15 minutes, the second buffer described in 350 μ L is added, 12000 revs/min, is centrifuged 30s, removes third filtrate;
Step 4: the RNA purification column that third filtrate is removed in step 3 is placed in 1.5mL without RNA hydrolase collecting pipe, to
The distilled water for removing RNA hydrolase of 50 μ L is added in RNA purification column or 0.1% pyrocarbonic acid diethyl ester handles water, is stored at room temperature 5 points
Clock, is centrifuged 2min, eluted rna purification column, using the OD260/OD280 of spectrophotometer measurement RNA solution by 12000 revs/min
When ratio is 1.7~2.1, RNA is obtained.
Or the method that RNA is extracted from nasal cavity cast-off cells, comprising the following steps:
Step 1: take genomic DNA adsorption column to be placed in 2mL collecting pipe, the nasal cavity cast-off cells are dissolved in 100~
It is added after in 2000 μ L cell pyrolysis liquids into genomic DNA adsorption column, takes filtrate, be added in equal volume into the filtrate
70% ethyl alcohol is added after mixing into RNA purification column, 12000 revs/min, is centrifuged 1min, filtrate is removed, by the RNA
Purification column is placed in 2mL collecting pipe;
Step 2: it is added the first buffer of 500 μ L into the RNA purification column obtained in step 1,12000 revs/min
Clock is centrifuged 30s, removes the first filtrate;Continue that 600 the second buffers of μ L are added to the RNA purification column, 12000 revs/min,
It is centrifuged 30s, removes the second filtrate;
Step 3: the RNA purification column that the second filtrate is removed in step 2 is placed in 1.5mL without RNA hydrolase collecting pipe, to
The distilled water for removing RNA hydrolase of 50 μ L is added in RNA purification column or 0.1% pyrocarbonic acid diethyl ester handles water, is stored at room temperature 5 points
Clock, is centrifuged 2min, eluted rna purification column, using the OD260/OD280 of spectrophotometer measurement RNA solution by 12000 revs/min
When ratio is 1.7~2.1, RNA is obtained.
Preferably, the second method for extracting RNA from nasal cavity cast-off cells, comprising the following steps: to being equipped with
Be added in the centrifuge tube of nasal cavity cast-off cells 0.1mL~20mL RNA extract dissolved, vibrate after RNA extracting is added
0.1~0.5 times of chloroform of liquid product, concussion mix, are stored at room temperature, the centrifuge tube is centrifuged, and take supernatant, described in addition
0.5~3 times of isopropanol of chloroform volume stands after mixing, is centrifuged, abandons supernatant, retains the first precipitating, to first precipitating
The ethyl alcohol of middle 0.5~5 times of the concentration 65%~90% that the isopropanol volume is added mixes, centrifugation after washed, in abandoning
Clearly, retain the second precipitating;The centrifuge tube is covered tightly, is centrifuged again, supernatant is removed, continues to be added 0.01 into the centrifuge tube
~5mL goes RNA enzyme and the water of DNA enzymatic is gone to dissolve second precipitating, using spectrophotometer measurement RNA purity, obtains RNA.
Preferably, the RNA extract is Trizol, RNAiso Blood, RNAiso Plus or other contain benzene
The reagent of any one or more of phenol, guanidinium isothiocyanate, 8-hydroxyquinoline, guanidinium isothiocyanate and beta -mercaptoethanol.
Preferably, the second method for extracting RNA from nasal cavity cast-off cells, comprising the following steps: to being equipped with
After addition 0.1~20mLRNA extract is dissolved, vibrated in the centrifuge tube of nasal cavity cast-off cells, it is stored at room temperature 3~7min;
40 μ L~5mL chloroforms are added, concussion mixes, and is stored at room temperature 3~7min, and in 3 DEG C~5 DEG C, 10000~14000r/min is centrifuged 10
~20min;40 μ L~8mL of supernatant is taken, isometric isopropanol is added, 8~12min is stood after mixing, in 3 DEG C~5 DEG C,
10000~14000r/min is centrifuged 10~20min and abandons supernatant, retains the first precipitating;Addition and isopropyl into first precipitating
The ethyl alcohol of the isometric concentration 65%~90% of alcohol, on 3 DEG C~5 DEG C, 7000~14000r/min, 10~20min of centrifugation, abandoning
Clearly, retain the second precipitating;The centrifuge tube is covered tightly, on 3 DEG C~5 DEG C, 7000~14000r/min, 1~3min of centrifugation, removing
Clear liquid, stand 10~20min after continue into the centrifuge tube be added 0.01~5mL go RNA enzyme and go DNA enzymatic water dissolve institute
The second precipitating is stated, using spectrophotometer measurement RNA purity, obtains RNA.
Specifically, the second method for extracting RNA from nasal cavity cast-off cells, comprising the following steps: to equipped with nose
After addition 1mLRNA extract is dissolved, vibrated in the centrifuge tube of chamber cast-off cells, it is stored at room temperature 5min;200 μ L chlorine are added
Imitative, concussion mixes, and is stored at room temperature 5min, and in 4 DEG C, 12000r/min is centrifuged 15min;200 μ L of supernatant is taken, it is different that 200 μ L are added
Propyl alcohol stands 10min after mixing, and in 4 DEG C, 12000r/min is centrifuged 15min and abandons supernatant, retains the first precipitating;To described first
The ethyl alcohol with the isometric concentration 75% of isopropanol is added in precipitating, in 4 DEG C, 7500r/min is centrifuged 15min, abandons supernatant, retains
Second precipitating;Cover tightly the centrifuge tube, in 4 DEG C, 7500r/min is centrifuged 2min, removes supernatant, stand continue after 15min to
50 μ L are added in the centrifuge tube to go RNA enzyme and the water of DNA enzymatic is gone to dissolve second precipitating, using spectrophotometer measurement
RNA solution OD260/OD280 ratio is 1.7~2.1, obtains RNA.
Preferably, by total serum IgE reverse transcription be cDNA method the following steps are included: the reverse transcription of 1~3 μ L is taken to mix
Liquid, 0~10 μ L go RNA hydrolase distilled water and the RNA of extraction to issue raw reverse transcription reaction 15min in 37 DEG C of temperature conditions,
The inactivation reaction for issuing raw reverse transcriptase in 84 DEG C of temperature conditions afterwards, obtains reverse transcription product cDNA.
More preferably, by total serum IgE reverse transcription be cDNA method the following steps are included: taking the reverse transcription of 2 μ L
Mixed liquor, the described of 8 μ L go RNA hydrolase distilled water and total amount to be no more than the total serum IgE of 500ng or volume no more than 8 μ L,
It is described to go RNA hydrolase distilled water polishing to 10 μ L;Reverse transcription reaction is carried out after soft mixing, condition is as follows: in 37 DEG C of item
Under part, 15 minutes reverse transcription reactions are carried out;Under conditions of 85 DEG C, the inactivation reaction of 5 seconds reverse transcriptase is carried out;Product 4
DEG C place.Wherein reaction system can accordingly amplify on demand, 10 μ L reaction systems can the maximum total serum IgE for using 500ng, this field
Technical staff can select according to actual needs.
Preferably, real-time fluorescence quantitative PCR amplification the following steps are included:
Step 1: preparing real-time fluorescence quantitative PCR reaction solution: the PCR premix including 1 μ of μ L~25 L, 0 μ of μ L~10 L
Distilled water polishing total volume water to 10 μ L, 0 μ of μ L~2 L machine fluorescence compensation and corrigent, 0.01~100 μM of CLC
The upstream primer of gene, the downstream primer of 0.01~100 μM of CLC gene, the upstream of 0.01~100 μM of reference gene is drawn
Object, the downstream primer of 0.01~100 μM of reference gene, the cDNA of 0.01 μ of μ L~5 L;
Step 2: it is fixed that real-time fluorescence being carried out using two-step method PCR amplification standardization program or three-step approach PCR amplification standardization program
Measure PCR detection;
Step 3: calculating CLC gene expression amount.
More preferably, prepare real-time fluorescence quantitative PCR reaction solution: the PCR premix including 5 μ L, 2.8 μ L's is double
Machine fluorescence compensation and corrigent, the upstream of the CLC gene of 0.5 μ L of the water polishing total volume water to 10 μ L, 0.2 μ L is steamed to draw
Draw in the downstream of object, the downstream primer of the CLC gene of 0.5 μ L, the upstream primer of the reference gene of 0.5 μ L, the reference gene of 0.5 μ L
The RNA of object, the cDNA of 1ng/ μ L or 0.01 μ L to 5 μ L.
Preferably, the reaction condition of the two-step method PCR amplification standardization program is the following steps are included: the 1st stage: 95
Initial denaturation 30 seconds under conditions of DEG C;The reaction of 2nd stage PCR: under conditions of 95 DEG C, reaction 15 seconds, under conditions of 60 DEG C, instead
It answers 60 seconds, annealing extends, and so carries out 40 circulations;
The reaction condition of the three-step approach PCR amplification standardization program is the following steps are included: the 1st stage: in 95 DEG C of condition
Lower initial denaturation 2 minutes;The reaction of 2nd stage PCR: under conditions of 95 DEG C, reacting 1 minute, under conditions of 55 DEG C, reacts 1 point
Clock reacts 1 minute under conditions of 72 DEG C, so carries out 40 circulations;Last 72 DEG C, annealing in 7 minutes extends;
The method for calculating the CLC gene expression amount are as follows: calculate Δ CT or 2-ΔΔCTTo calculate the expression quantity of target gene;
Wherein Δ CT=(CT (CLC)-CT (GAPDH)) ,-Δ Δ CT=- (Δ CT (processing sample CT (CLC)-CT (GAPDH))-health
Control group average delta CT);The each control group Δ CT of healthy control group average delta CT=∑ (CT (CLC)-CT (GAPDH))/control
Group sample number.
The method of CLC gene expression amount is in preparation for detecting with nasal polyp in a kind of above-mentioned detection nasal cavity cast-off cells
Chronic nasosinusitis hypotype kit in application.
Compared with prior art, the advantages and positive effects of the present invention are:
1, the method provided by the invention for detecting CLC gene expression amount in nasal cavity cast-off cells, with the CLC base of Effective selection
Because as biomarker, providing the detection method to its gene expression amount, realize to CLC gene expression in nasal cavity cast-off cells
The calculating of amount can effectively obtain CLC gene expression amount, and the method provided is simple and fast, and sensibility is high, reproducible, be suitable for
Wide popularization and application.
2, the method provided by the invention for detecting CLC gene expression amount in nasal cavity cast-off cells, wherein CLC gene is acidophilus
The lysophospholipase expressed in property granulocyte and basophilic granulocyte.Lysophosphatidyl choline is hydrolyzed to choline glycerophosphatide by it
And free fatty acid.The albumen may have carbohydrate or IgE to combine activity.It structurally and functionally all with β-gala
The protein-bonded galactose agglutinin family of glucosides is related.It is related with inflammation and some myelocytic leukemias.It is relevant to CLC
Disease includes auto-inflammatory, lipodystrophy and skin disease syndrome.What wherein invention provided is directed in nasal cavity cast-off cells
The method of CLC gene expression amount can be used for detecting CLC expression in nasal cavity cast-off cells.
3, the method provided by the invention for detecting CLC gene expression amount in nasal cavity cast-off cells, uses according to actual needs
Δ Ct or 2-ΔΔCtThe relative quantification method of method has selected the relative constant reference gene of expression quantity, has been carried out with the quantity of reference gene
Standardization, by measuring the different calculating destination gene expression amount of Ct value difference of sample target gene and reference gene, method is easy to be fast
Speed, detection accuracy is high, can reduce testing cost, saves detection time.As a result the advantages that being convenient for interpretation.Greatly improve experiment effect
Rate.
4, the method provided by the invention for detecting CLC gene expression amount in nasal cavity cast-off cells, in the future for nose
The detection genescreen technology of the chronic nasosinusitis hypotype of polyp provides the foundation, and providing for clinical guidance and drug therapy can
The basis leaned on.It ensure that for detecting the kit with the chronic nasosinusitis hypotype of nasal polyp in the feasibility of clinical application.
Specific embodiment
The technical scheme in the embodiments of the invention will be clearly and completely described below, it is clear that described implementation
Example is only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, this field is common
Technical staff's every other embodiment obtained without making creative work belongs to the model that the present invention protects
It encloses.
It is including following the embodiment of the invention provides a kind of method of CLC gene expression amount in detection nasal cavity cast-off cells
Step: extracting RNA from nasal cavity cast-off cells, is cDNA by total serum IgE reverse transcription, will be in cDNA using quantitative polyase chain reaction
CLC gene and reference gene specific primer and reference gene that CLC gene is respectively adopted specific primer carry out it is real-time
Fluorescent quantitative PCR, the testing result based on amplified production calculate CLC gene expression amount.
The present invention screens to obtain by proteomics and transcription group method through a large amount of creative experiments passes through calculating
CLC gene expression amount is come the calculating for CLC gene expression amount that detects the chronic nasosinusitis hypotype with nasal polyp, and provide
Method is easy to be reliable, and accuracy is high.Corresponding any report is not yet provided in current existing technology.Wherein it is directed to CLC gene
For known, gene I/D 1178, as shown in seqid no:1, gene NM is 001828.5 to DNA sequence dna.
In an alternative embodiment, the upstream primer of CLC gene is as shown in SEQIDNO:2, and the downstream primer of CLC gene is such as
Shown in SEQIDNO:3.For the design of the upstream primer and downstream primer of CLC gene, sensibility is higher, is carrying out detection CLC
When gene expression amount, keep result more acurrate, repeatability is more preferable.
In an alternative embodiment, the reference gene is GAPDH, the upstream primer of the reference gene such as SEQIDNO:
Shown in 4, the downstream primer is as shown in SEQIDNO:5.Design of feature at this is drawn in conjunction with the upstream of above-mentioned CLC gene
The downstream primer of object and CLC gene obtains suitable Δ CT value, to carry out CLC gene expression amount calculating, and standard with higher
True rate.
In an alternative embodiment, the nasal cavity cast-off cells are obtained using hairbrush in nasal polyp surface, and will acquire nose
Hairbrush after chamber cast-off cells is placed in cell pyrolysis liquid to be saved in 4 DEG C or less.Method of the invention is based on this kind of mode and avoids
The surface of a wound is caused to patient, improves the safety of patient's inspection, and operate it is more convenient, saved human cost and see a doctor at
This.
In an alternative embodiment, the method that RNA is extracted from nasal cavity cast-off cells, including two methods, wherein first
Kind of method the following steps are included:
Step 1: the nasal cavity cast-off cells being dissolved in 100~2000 μ L cell pyrolysis liquids, and are added in equal volume
Ethyl alcohol is added after mixing into RNA purification column, after centrifugal treating, removes the filtrate in collecting pipe, the RNA is purified
Column is placed in collecting pipe;
Step 2: the first buffer of 300 μ of μ L~700 L being added into the RNA purification column obtained in step 1, is centrifuged
After processing, the first filtrate is removed;Continue that 400 μ of μ L~800 the second buffers of L are added to the RNA purification column, after centrifugal treating,
The second filtrate is removed, takes RNA purification column through affording RNA.
Preferably, the method for extracting RNA from nasal cavity cast-off cells, further comprising the steps of: to described in removing
10~100 μ L DNA enzymatic reaction solutions are added in RNA purification column after second filtrate, and after stewing process, 300 μ of μ L~700 are added
Second buffer described in L after centrifugal treating, removes third filtrate, takes RNA purification column after eluting using spectrophotometer measurement
RNA purity, obtains RNA;
The preparation method of the DNA enzymatic reaction solution goes RNA enzyme the following steps are included: take DNA enzymatic buffer, recombinant dnase
Distilled water be mixed to get DNA enzymatic reaction solution.It is preferred that the preparation method of the DNA enzymatic reaction solution is the following steps are included: take 5 μ L
10 × DNA enzymatic buffer, 4 μ L recombinant dnases, 41 μ L go the distilled water of RNA enzyme to be mixed to get DNA enzymatic reaction solution.
Preferably, genome content is lower or when material initial amount is less when carrying out RNA extraction, it is described de- from nasal cavity
The method for extracting RNA is fallen in cell, and further comprising the steps of: in the step 1, the nasal cavity cast-off cells are dissolved in cell and split
It is first added after in solution liquid into genomic DNA adsorption column and takes filtrate, then isometric ethyl alcohol is added into the filtrate.
Preferably, in order to obtain the RNA of higher concentration, the method that RNA is extracted from nasal cavity cast-off cells is also wrapped
It includes following steps: taking RNA purification column to be eluted that the distilled water for removing RNA hydrolase or pyrocarbonic acid diethyl ester processing water, room is added
After temperature is stood, RNA is obtained using spectrophotometer measurement RNA purity through centrifugal treating, the elution RNA purification column.
Wherein step 1 can be crushed rapidly nasal cavity cast-off cells using cell pyrolysis liquid and nasal cavity cast-off cells is inhibited to discharge
The substance of nuclease out;Using genomic DNA adsorption column for removing genomic DNA;RNA purification column in step 2 is used for
It is enriched with RNA;Wherein collecting pipe be used for collects remove genomic DNA after solution, for remove be adsorbed with RNA purification column it is miscellaneous
First buffer of matter, the second buffer for removing impurity and salinity in RNA solution.
Specifically, the first method for extracting RNA from nasal cavity cast-off cells, comprising the following steps:
Step 1: the nasal cavity cast-off cells being dissolved in 300 μ L cell pyrolysis liquids, and 70% isometric second is added
Solution is uniformly mixed by alcohol using liquid-transfering gun;Mixed liquor is added into RNA purification column immediately, 12000 revs/min, is centrifuged
1min removes filtrate, the RNA purification column is placed in 2mL collecting pipe;
Step 2: it is added the first buffer of 500 μ L into the RNA purification column obtained in step 1,12000 revs/min
Clock is centrifuged 30s, removes the first filtrate;Continue that 600 the second buffers of μ L are added to the RNA purification column, 12000 revs/min,
It is centrifuged 30s, removes the second filtrate;
Step 3: taking 5 μ 10 × DNA enzymatic of L buffers, 4 μ L recombinant dnases, 41 μ L go the distilled water of RNA enzyme through mixing
To DNA enzymatic reaction solution, 50 μ L DNA enzymatic reaction solutions are added into the RNA purification column after removing second filtrate, are stored at room temperature
15 minutes, the second buffer described in 350 μ L is added, 12000 revs/min, is centrifuged 30s, removes third filtrate;
Step 4: the RNA purification column that third filtrate is removed in step 3 is placed in 1.5mL without RNA hydrolase collecting pipe, to
The distilled water for removing RNA hydrolase of 50 μ L is added in RNA purification column or 0.1% pyrocarbonic acid diethyl ester handles water, is stored at room temperature 5 points
Clock, is centrifuged 2min, eluted rna purification column, using the OD260/OD280 of spectrophotometer measurement RNA solution by 12000 revs/min
When ratio is 1.7~2.1, RNA is obtained.
Or the method that RNA is extracted from nasal cavity cast-off cells, comprising the following steps:
Step 1: take genomic DNA adsorption column to be placed in 2mL collecting pipe, the nasal cavity cast-off cells are dissolved in 100~
It is added after in 2000 μ L cell pyrolysis liquids into genomic DNA adsorption column, takes filtrate, isometric 70% is added into the filter
Ethyl alcohol is added after mixing into RNA purification column, 12000 revs/min, is centrifuged 1min, is removed filtrate, the RNA is purified
Column is placed in 2mL collecting pipe;
Step 2: it is added the first buffer of 500 μ L into the RNA purification column obtained in step 1,12000 revs/min
Clock is centrifuged 30s, removes the first filtrate;Continue that 600 the second buffers of μ L are added to the RNA purification column, 12000 revs/min,
It is centrifuged 30s, removes the second filtrate;
Step 3: the RNA purification column that the second filtrate is removed in step 2 is placed in 1.5mL without RNA hydrolase collecting pipe, to
The distilled water for removing RNA hydrolase of 50 μ L is added in RNA purification column or 0.1% pyrocarbonic acid diethyl ester handles water, is stored at room temperature 5 points
Clock, is centrifuged 2min, eluted rna purification column, using the OD260/OD280 of spectrophotometer measurement RNA solution by 12000 revs/min
When ratio is 1.7~2.1, RNA is obtained.
Wherein step 1 can be crushed rapidly nasal cavity cast-off cells using cell pyrolysis liquid and nasal cavity cast-off cells is inhibited to discharge
The substance of nuclease out;Step 1 is using genomic DNA adsorption column for removing genomic DNA;RNA purification column in step 2
For being enriched with RNA;Wherein collecting pipe is used to collect the solution after removal genomic DNA, for removing the purification column for being adsorbed with RNA
Impurity the first buffer, the second buffer for removing impurity and salinity in RNA solution.
In an alternative embodiment, the second method of RNA is extracted from nasal cavity cast-off cells, comprising the following steps: to
In centrifuge tube equipped with nasal cavity cast-off cells be added 0.1mL~20mL RNA extract dissolved, vibrate after the RNA is added
0.1~0.5 times of chloroform of extract volume, concussion mix, are stored at room temperature, the centrifuge tube is centrifuged, take supernatant, are added
0.5~3 times of isopropanol of the chloroform volume stands after mixing, is centrifuged, abandons supernatant, retains the first precipitating, to described first
The ethyl alcohol of 0.5~5 times of concentration 65%~90% of the isopropanol volume is added in precipitating, mixes, centrifugation, abandons after washed
Supernatant retains the second precipitating;The centrifuge tube is covered tightly, is centrifuged again, supernatant is removed, continues to be added into the centrifuge tube
0.01~5mL goes RNA enzyme and the water of DNA enzymatic is gone to dissolve second precipitating, using spectrophotometer measurement RNA purity, obtains
RNA。
It is preferred that the RNA extract is Trizol, RNAiso Blood, RNAiso Plus or other contain phenol, different sulphur
The reagent of any one or more of cyanic acid guanidine, 8-hydroxyquinoline, guanidinium isothiocyanate and beta -mercaptoethanol.
In a preferred embodiment, the second method that RNA is extracted from nasal cavity cast-off cells, including following step
It is rapid: after into the centrifuge tube equipped with nasal cavity cast-off cells, addition 0.1~20mLRNA extract is dissolved, vibrated, to be stored at room temperature
3~7min;It is added 40 μ L~5mL chloroforms, concussion mixes, it is stored at room temperature 3~7min, in 3 DEG C~5 DEG C, 10000~14000r/
Min is centrifuged 10~20min;40 μ L~8mL of supernatant is taken, isometric isopropanol is added, 8~12min is stood after mixing, in 3
DEG C~5 DEG C, 10000~14000r/min is centrifuged 10~20min and abandons supernatant, retains the first precipitating;Add into first precipitating
The ethyl alcohol for entering the concentration 65%~90% isometric with isopropanol, in 3 DEG C~5 DEG C, 7000~14000r/min centrifugation 10~
20min abandons supernatant, retains the second precipitating;The centrifuge tube is covered tightly, in 3 DEG C~5 DEG C, 7000~14000r/min centrifugation 1~
3min removes supernatant, continues 0.01~5mL of addition into the centrifuge tube after 10~20min of standing and goes RNA enzyme and remove DNA
The water dissolution of enzyme second precipitating, using spectrophotometer measurement RNA purity, obtains RNA.
Specifically, extracting the second method of RNA from nasal cavity cast-off cells, comprising the following steps: taken off to equipped with nasal cavity
It falls in the centrifuge tube of cell and is added after 1mLRNA extract dissolved, vibrated, be stored at room temperature 5min;200 μ L chloroforms are added, shake
Mixing is swung, 5min is stored at room temperature, in 4 DEG C, 12000r/min is centrifuged 15min;200 μ L of supernatant is taken, 200 μ L isopropanols are added,
10min is stood after mixing, in 4 DEG C, 12000r/min is centrifuged 15min and abandons supernatant, retains the first precipitating;Into first precipitating
The ethyl alcohol with the isometric concentration 75% of isopropanol is added, in 4 DEG C, 7500r/min is centrifuged 15min, abandons supernatant, and it is heavy to retain second
It forms sediment;Cover tightly the centrifuge tube, in 4 DEG C, 7500r/min is centrifuged 2min, removes supernatant, stand continue after 15min to it is described from
50 μ L are added in heart pipe to go RNA enzyme and the water of DNA enzymatic is gone to dissolve second precipitating, using spectrophotometer measurement RNA solution
OD260/OD280 ratio is 1.7~2.1, obtains RNA.
Preferably, by total serum IgE reverse transcription be cDNA method the following steps are included: the reverse transcription of 1~3 μ L is taken to mix
Liquid, 0~10 μ L go RNA hydrolase distilled water and the RNA of extraction to issue raw reverse transcription reaction 15min in 37 DEG C of temperature conditions,
The inactivation reaction for issuing raw reverse transcriptase in 84 DEG C of temperature conditions afterwards, obtains reverse transcription product cDNA.
In an alternative embodiment, by method that total serum IgE reverse transcription is cDNA the following steps are included: taking that 2 μ L's is described inverse
Mixed liquor is transcribed, the described of 8 μ L goes RNA hydrolase distilled water and total amount total no more than 8 μ L no more than 500ng or volume
RNA, it is described to go RNA hydrolase distilled water polishing to 10 μ L;Reverse transcription reaction is carried out after soft mixing, condition is as follows: at 37 DEG C
Under conditions of, carry out 15 minutes reverse transcription reactions;Under conditions of 85 DEG C, the inactivation reaction of 5 seconds reverse transcriptase is carried out;It produces
4 DEG C of object placements.
In an alternative embodiment, real-time fluorescence quantitative PCR amplification the following steps are included:
Step 1: preparing real-time fluorescence quantitative PCR reaction solution: the PCR premix including 1 μ of μ L~25 L, 0 μ of μ L~10 L
Distilled water polishing total volume water to 10 μ L, 0 μ of μ L~2 L machine fluorescence compensation and corrigent, 0.01~100 μM of CLC
The upstream primer of gene, the downstream primer of 0.01~100 μM of CLC gene, the upstream of 0.01~100 μM of reference gene is drawn
Object, the downstream primer of 0.01~100 μM of reference gene, the cDNA of 0.01 μ of μ L~5 L;
Step 2: it is fixed that real-time fluorescence being carried out using two-step method PCR amplification standardization program or three-step approach PCR amplification standardization program
Measure PCR detection;
Step 3: calculating CLC gene expression amount.
Specifically, preparing real-time fluorescence quantitative PCR reaction solution: the distilled water of the PCR premix including 5 μ L, 2.8 μ L is mended
Machine fluorescence compensation and corrigent of the neat total volume water to 10 μ L, 0.2 μ L, the upstream primer of the CLC gene of 0.5 μ L, 0.5 μ L
CLC gene downstream primer, the upstream primer of the reference gene of 0.5 μ L, the downstream primer of the reference gene of 0.5 μ L, 1ng/ μ
The cDNA of L.
In an alternative embodiment, the reaction condition of the two-step method PCR amplification standardization program is the following steps are included: the 1st
Stage: the initial denaturation 30 seconds under conditions of 95 DEG C;The reaction of 2nd stage PCR: it under conditions of 95 DEG C, reacts 15 seconds, at 60 DEG C
Under the conditions of, it reacts 60 seconds, annealing extends, and so carries out 40 circulations;
The reaction condition of the three-step approach PCR amplification standardization program is the following steps are included: the 1st stage: in 95 DEG C of condition
Lower initial denaturation 2 minutes;The reaction of 2nd stage PCR: under conditions of 95 DEG C, reacting 1 minute, under conditions of 55 DEG C, reacts 1 point
Clock reacts 1 minute under conditions of 72 DEG C, so carries out 40 circulations;Last 72 DEG C, annealing in 7 minutes extends;
The method for calculating the CLC gene expression amount are as follows: calculate Δ CT or 2-ΔΔCTTo calculate the expression quantity of target gene;
Wherein Δ CT=(CT (CLC)-CT (GAPDH)) ,-Δ Δ CT=- (Δ CT (processing sample CT (CLC)-CT (GAPDH))-health
Control group average delta CT);The each control group Δ CT of healthy control group average delta CT=∑ (CT (CLC)-CT (GAPDH))/control
Group sample number.Using Δ CT method or 2-ΔΔCtThe relative quantification method of method has selected the relative constant reference gene of expression quantity, with interior
The quantity of ginseng gene is standardized, by the different calculating target gene table of Ct value difference for measuring sample target gene and reference gene
Up to amount, method is easy quickly, and detection accuracy is high, can reduce testing cost, saves detection time.As a result the advantages that being convenient for interpretation.
Greatly improve conventional efficient.
It is specifically directed to the expression difference of same subject CLC and reference gene, reference gene is that expression is more steady in vivo
Fixed gene will not usually change with disease etc., therefore be able to reflect compared with reference gene target gene and reference gene
Δ CT method then can be used in relative abundance.It then can be used 2 for the expression difference of different subject CLC and reference gene-ΔΔCt
Method.
The method of CLC gene expression amount is in preparation for detecting with nasal polyp in a kind of above-mentioned detection nasal cavity cast-off cells
Chronic nasosinusitis hypotype kit in application.
CLC gene in a kind of detection nasal cavity cast-off cells provided by the embodiment of the present invention is introduced in detail in order to become apparent from
The method and application of expression quantity, are described below in conjunction with specific embodiment.
Embodiment 1:
The collection and processing of sample:
After certain patient normal saline flushing nasal cavity, with hairbrush (production of Copan company) in nasal polyp surface under nasal endoscopes
30s, 3~4 circle of rotation are pressed, hairbrush is placed in by lysate by swipe polyp surface, 4 DEG C of short-term preservations (being no more than 24 hours),
Or it is transferred to lower than -20 DEG C of long-term preservations.
A method of CLC gene expression amount in detection nasal cavity cast-off cells, comprising the following steps:
Step 1: RNA is extracted from nasal cavity cast-off cells:
Step 1: taking genomic DNA adsorption column to be placed in 2mL collecting pipe, the nasal cavity cast-off cells are dissolved in 300 μ L
It is added after in cell pyrolysis liquid into genomic DNA adsorption column, takes filtrate, 70% isometric ethyl alcohol is added into the filter,
It is added after mixing into RNA purification column, 12000 revs/min, is centrifuged 1min, removed filtrate, the RNA purification column is set
In 2mL collecting pipe;
Step 2: it is added the first buffer of 500 μ L into the RNA purification column obtained in step 1,12000 revs/min
Clock is centrifuged 30s, removes the first filtrate;Continue that 600 the second buffers of μ L are added to the RNA purification column, 12000 revs/min,
It is centrifuged 30s, removes the second filtrate;
Step 3: the RNA purification column that the second filtrate is removed in step 2 is placed in 1.5mL without RNA hydrolase collecting pipe, to
The distilled water for removing RNA hydrolase of 50 μ L is added in RNA purification column or 0.1% pyrocarbonic acid diethyl ester handles water, is stored at room temperature 5 points
Clock, is centrifuged 2min, eluted rna purification column, using the OD260/OD280 of spectrophotometer measurement RNA solution by 12000 revs/min
Ratio is 2.0, obtains RNA;
Step 2: reverse transcription prepares cDNA, comprising the following steps: takes the reverse transcription mixed liquor of 2 μ L, the institute of 0~8 μ L
RNA hydrolase distilled water is stated (to be no more than 500ng according to RNA amount water polishing to 8 μ L) and total amount or volume is no more than 8 μ
The total serum IgE of L, it is described to go RNA hydrolase distilled water polishing to 10 μ L;Reverse transcription reaction is carried out after soft mixing, condition is as follows:
Under conditions of 37 DEG C, 15 minutes reverse transcription reactions are carried out;Under conditions of 85 DEG C, the inactivation for carrying out 5 seconds reverse transcriptase is anti-
It answers;4 DEG C of product placements.
Step 3: real-time fluorescence quantitative PCR augmentation detection, comprising the following steps:
Step 1: preparing real-time fluorescence quantitative PCR reaction solution: the PCR premix including 1 μ L, the distilled water of 0-10 μ L
(according to total volume water polishing to 10 μ L), the machine fluorescence compensation of 0.2 μ L and corrigent, the upstream of 1 μM of CLC gene are drawn
Object, the downstream primer of 1 μM of CLC gene, the upstream primer of 1 μM of reference gene, the downstream primer of 1 μM of reference gene,
The cDNA of 0.01 μ L, the positive control of 1 μ g, the negative control of 1 μ g, positive control are the plasmid containing CLC, negative control
It is empty plasmid (plasmid vector);
Step 2: using two-step method PCR amplification standardization program: the reaction condition packet of the two-step method PCR amplification standardization program
Include following steps: the 1st stage: the initial denaturation 30 seconds under conditions of 95 DEG C;2nd stage PCR reaction: under conditions of 95 DEG C, instead
It answers 15 seconds, under conditions of 60 DEG C, reacts 60 seconds, annealing extends, and so carries out 40 circulations.
Step 4: the CLC gene expression amount is calculated:
The amplification curve and melting curve for confirming real-time fluorescence quantitative PCR after reaction, read the Ct of CLC and GAPDH
Value selects △ Ct analytic approach (the Ct value of CLC subtracts the Ct value of GAPDH) to be analyzed, using GAPDH as reference gene;It is positive
Control Ct value<20 and negative control Ct value>38 are considered as experiment effectively, and otherwise experiment is invalid;
The Δ CT method that the present embodiment uses compares the expression difference of CLC and reference gene: CLC mean CT-number for
20.1, GAPDH mean CT-number is 18.9, and Δ CT value is 1.2.
Embodiment 2:
The collection and processing of sample:
After certain patient normal saline flushing nasal cavity, with hairbrush (production of Copan company) in nasal polyp surface under nasal endoscopes
30s, 3~4 circle of rotation are pressed, hairbrush is placed in by lysate by swipe polyp surface, 4 DEG C of short-term preservations (being no more than 24 hours),
Or it is transferred to lower than -20 DEG C of long-term preservations.
A method of CLC gene expression amount in detection nasal cavity cast-off cells, comprising the following steps:
Step 1: RNA is extracted from nasal cavity cast-off cells:
Step 1: taking genomic DNA adsorption column to be placed in 2mL collecting pipe, the nasal cavity cast-off cells are dissolved in 100 μ L
It is added after in cell pyrolysis liquid into genomic DNA adsorption column, is centrifuged 60s under conditions of 12000 turns/min, takes filtrate, to
70% isometric ethyl alcohol is added in the filter, is added after mixing into RNA purification column, 12000 revs/min, centrifugation
1min removes filtrate, the RNA purification column is placed in 2mL collecting pipe;
Step 2: it is added the first buffer of 300 μ L into the RNA purification column obtained in step 1,12000 revs/min
Clock is centrifuged 30s, removes the first filtrate;Continue that 400 the second buffers of μ L are added to the RNA purification column, 12000 revs/min,
It is centrifuged 30s, removes the second filtrate;
Step 3: the RNA purification column that the second filtrate is removed in step 2 is placed in 1.5mL without RNA hydrolase collecting pipe, to
The distilled water for removing RNA hydrolase of 50 μ L is added in RNA purification column or 0.1% pyrocarbonic acid diethyl ester handles water, is stored at room temperature 5 points
Clock, is centrifuged 2min, eluted rna purification column, using the OD260/OD280 of spectrophotometer measurement RNA solution by 12000 revs/min
Ratio is 2.0, obtains RNA;
Step 2: reverse transcription prepares cDNA, comprising the following steps: the reverse transcription mixed liquor of 1 μ L is taken, 0~10 μ L's
It is described that RNA hydrolase distilled water and total amount is gone to be no more than the total serum IgE of 500ng or volume no more than 8 μ L, it is described that RNA is gone to hydrolyze
Enzyme distilled water polishing is to 10 μ L;Reverse transcription reaction is carried out after soft mixing, condition is as follows: under conditions of 37 DEG C, carrying out 15 points
The reverse transcription reaction of clock;Under conditions of 85 DEG C, the inactivation reaction of 5 seconds reverse transcriptase is carried out;4 DEG C of product placements.
Step 3: real-time fluorescence quantitative PCR augmentation detection, comprising the following steps:
Step 1: preparing real-time fluorescence quantitative PCR reaction solution: the PCR premix including 25 μ L, the distilled water of 0~10 μ L
(according to total volume water polishing to 10 μ L), the dyestuff (fluorescence for carrying out machine compensates and correction) of 0~2 μ L, 0.01 μM
CLC gene upstream primer, the downstream primer of 0.01 μM of CLC gene, the upstream primer of 0.01 μM of reference gene, 0.01
μM reference gene downstream primer, the cDNA of 5 μ L, 1 μ g positive control, 1 μ g negative control, positive control is containing CLC
Plasmid, negative control are empty plasmid (plasmid vectors);
Step 2: using two-step method PCR amplification standardization program: the reaction condition packet of the two-step method PCR amplification standardization program
Include following steps: the 1st stage: the initial denaturation 30 seconds under conditions of 95 DEG C;2nd stage PCR reaction: under conditions of 95 DEG C, instead
It answers 15 seconds, under conditions of 60 DEG C, reacts 60 seconds, annealing extends, and so carries out 40 circulations.
Step 4: the CLC gene expression amount is calculated:
The amplification curve and melting curve for confirming real-time fluorescence quantitative PCR after reaction, read the Ct of CLC and GAPDH
Value selects △ Ct analytic approach (the Ct value of CLC subtracts the Ct value of GAPDH) to be analyzed, using GAPDH as reference gene;It is positive
Control Ct value<20 and negative control Ct value>38 are considered as experiment effectively, and otherwise experiment is invalid;
It uses Δ CT method to compare the expression difference of CLC and reference gene: obtaining the mean CT-number of CLC as 24.5, GAPDH
Mean CT-number be 18.0, Δ CT value be 6.5.
Embodiment 3:
The collection and processing of sample:
After certain patient normal saline flushing nasal cavity, with hairbrush (production of Copan company) in nasal polyp surface under nasal endoscopes
30s, 3~4 circle of rotation are pressed, hairbrush is placed in by lysate by swipe polyp surface, 4 DEG C of short-term preservations (being no more than 24 hours),
Or it is transferred to lower than -20 DEG C of long-term preservations.
A method of CLC gene expression amount in detection nasal cavity cast-off cells, comprising the following steps:
Step 1: RNA is extracted from nasal cavity cast-off cells:
Step 1: taking genomic DNA adsorption column to be placed in 2mL collecting pipe, the nasal cavity cast-off cells are dissolved in 2000 μ L
It is added after in cell pyrolysis liquid into genomic DNA adsorption column, is centrifuged 60s under conditions of 12000 turns/min, takes filtrate, to
70% isometric ethyl alcohol is added in the filter, is added after mixing into RNA purification column, 12000 revs/min, centrifugation
1min removes filtrate, the RNA purification column is placed in 2mL collecting pipe;
Step 2: it is added the first buffer of 700 μ L into the RNA purification column obtained in step 1,12000 revs/min
Clock is centrifuged 30s, removes the first filtrate;Continue that 800 the second buffers of μ L are added to the RNA purification column, 12000 revs/min,
It is centrifuged 30s, removes the second filtrate;
Step 3: the RNA purification column that the second filtrate is removed in step 2 is placed in 1.5mL without RNA hydrolase collecting pipe, to
The distilled water for removing RNA hydrolase of 50 μ L is added in RNA purification column or 0.1% pyrocarbonic acid diethyl ester handles water, is stored at room temperature 5 points
Clock, is centrifuged 2min, eluted rna purification column, using the OD260/OD280 of spectrophotometer measurement RNA solution by 12000 revs/min
Ratio is 2.0, obtains RNA;
Step 2: reverse transcription prepares cDNA, comprising the following steps: takes the reverse transcription mixed liquor of 3 μ L, 0~8 μ L is gone
RNA enzyme and the water of DNA enzymatic is gone (to be no more than 500ng according to RNA amount water polishing to 8 μ L) and total amount or volume is no more than 8 μ L
Total serum IgE, it is described to go RNA hydrolase distilled water polishing to 10 μ L;Reverse transcription reaction is carried out after soft mixing, condition is as follows:
Under conditions of 37 DEG C, 15 minutes reverse transcription reactions are carried out;Under conditions of 85 DEG C, the inactivation for carrying out 5 seconds reverse transcriptase is anti-
It answers;4 DEG C of product placements.
Step 3: real-time fluorescence quantitative PCR augmentation detection, comprising the following steps:
Step 1: preparing real-time fluorescence quantitative PCR reaction solution: (gentle containing enzyme required for PCR including 5 μ L premixs
Fliud flushing), (according to total volume with water polishing to 10 μ L), the dyestuff of 0~2 μ L is (for carrying out the glimmering of machine for the distilled water of 0-10 μ L
Light compensation and correction), the upstream primer of 1 μM of CLC gene, the downstream primer of 1 μM of CLC gene, 1 μM of reference gene it is upper
Swim primer, the downstream primer of 1 μM of reference gene, the cDNA of 2 μ L, 1 μ g positive control, 1 μ g negative control;
Step 2: using two-step method PCR amplification standardization program: the reaction condition packet of the two-step method PCR amplification standardization program
Include following steps: the 1st stage: the initial denaturation 30 seconds under conditions of 95 DEG C;2nd stage PCR reaction: under conditions of 95 DEG C, instead
It answers 15 seconds, under conditions of 60 DEG C, reacts 60 seconds, annealing extends, and so carries out 40 circulations.
Step 4: the CLC gene expression amount is calculated:
The amplification curve and melting curve for confirming real-time fluorescence quantitative PCR after reaction, read the Ct of CLC and GAPDH
Value selects △ Ct analytic approach (the Ct value of CLC subtracts the Ct value of GAPDH) to be analyzed, using GAPDH as reference gene;It is positive
Control Ct value<20 and negative control Ct value>38 are considered as experiment effectively, and otherwise experiment is invalid;
It uses Δ CT method to compare the expression difference of CLC and reference gene: obtaining the mean CT-number of CLC as 24.0, GAPDH
Mean CT-number be 17.9, Δ CT value be 6.1.
In the above embodiment of the present invention 1~3, the manufacturer of preferred first buffer RWA buffer used is
Takara company, article No. 9767;The manufacturer of second buffer RWB buffer is Takara company, article No. 9767.But this
Application protection scope is simultaneously confined to above-mentioned the first buffer and the second buffer.Those skilled in the art can be according to practical application
It is selected.
Embodiment 4:
The collection and processing of sample:
After 78 subjects normal saline flushing nasal cavity, with hairbrush (production of Copan company) in nasal polyp under nasal endoscopes
Surface presses 30s, rotation 3-4 circle, and hairbrush is placed in the subsequent lysate by swipe polyp surface, and 4 DEG C of short-term preservations are (no
More than 24 hours), or be transferred to lower than -20 DEG C of long-term preservations.
A method of CLC gene expression amount in detection nasal cavity cast-off cells, comprising the following steps:
Step 1: RNA is extracted from nasal cavity cast-off cells: 1mLRNA is added into the centrifuge tube equipped with nasal cavity cast-off cells
After extract is dissolved, vibrated, it is stored at room temperature 5min;200 μ L chloroforms are added, concussion mixes, it is stored at room temperature 5min, in 4 DEG C,
12000r/min is centrifuged 15min;200 μ L of supernatant is taken, 200 μ L isopropanols are added, stand 10min after mixing, in 4 DEG C,
12000r/min is centrifuged 15min and abandons supernatant, retains the first precipitating;To it is described first precipitating in be added with isopropanol in equal volume it is dense
The ethyl alcohol of degree 75%, in 4 DEG C, 7500r/min is centrifuged 15min, abandons supernatant, retains the second precipitating;The centrifuge tube is covered tightly, in 4
DEG C, 7500r/min is centrifuged 2min, removes supernatant, stands to continue 50 μ L are added into the centrifuge tube after 15min and goes RNA enzyme
And the water of DNA enzymatic is gone to dissolve second precipitating, use spectrophotometer measurement RNA solution OD260/OD280 ratio for 1.8,
Obtain RNA;
Step 2: reverse transcription prepares cDNA step with embodiment one.
Step 3: real-time fluorescence quantitative PCR augmentation detection step is the same as embodiment one.
Step 4: the CLC gene expression amount is calculated:
The amplification curve and melting curve for confirming real-time fluorescence quantitative PCR after reaction, read the Ct of CLC and GAPDH
Value selects △ Ct analytic approach (the Ct value of CLC subtracts the Ct value of GAPDH) to be analyzed, using GAPDH as reference gene;It is positive
Control Ct value<20 and negative control Ct value>38 are considered as experiment effectively, and otherwise experiment is invalid;
Step 1: calculate healthy control group average delta CT: subject 1~10 is healthy control group in this example,
Calculation method is as follows: average delta CT (CT (CLC)-CT (GAPDH))=(5.304+6.364+6.733+4.366+
5.709+6.338+5.894+6.25+6.319+5.649)/10=5.8926;
Step 2: calculate subject's relative expression quantity:
On the basis of 5.8926, finding out each subject's relative expression quantity (indicates Ben Jiyin relative healths in subject
Compare cell mean expression height, numerical value represent variation multiple, such as 1.5 be equivalent to the subject expression quantity be health it is right
According to 1.5 times of cell mean), calculated result is as shown in table 1.
Calculation formula is 2-ΔΔCT(Δ CT (subject CT (CLC)-CT (GAPDH))-average delta CT is (strong by ,-Δ Δ CT=-
Health control group average delta CT)).
The CLC gene expression amount calculated result for the method that 1 embodiment 2 of table provides
Embodiment 5:
The collection and processing of sample:
Patient's normal saline flushing nasal cavity is advised before obtaining cell, with hairbrush (production of Copan company) in nose under nasal endoscopes
Polyp surface presses 30s, rotation 3-4 circle, and hairbrush is placed in lysate by swipe polyp surface, and 4 DEG C of short-term preservations (are no more than
24 hours), or be transferred to lower than -20 DEG C of long-term preservations.
A method of CLC gene expression amount in detection nasal cavity cast-off cells, comprising the following steps:
Step 1: from nasal cavity cast-off cells extract RNA step: to equipped with nasal cavity cast-off cells centrifuge tube in be added
After 20mLRNA extract is dissolved, vibrated, it is stored at room temperature 7min;10mL chloroform is added, concussion mixes, it is stored at room temperature 7min,
In 5 DEG C, 14000r/min is centrifuged 20min;Supernatant 20mL is taken, the isopropanol of 20mL is added, 12min is stood after mixing, in 5
DEG C, 14000r/min is centrifuged 20min and abandons supernatant, retains the first precipitating;The concentration 90% of 40mL is added into first precipitating
Ethyl alcohol, in 5 DEG C, 14000r/min is centrifuged 3min, abandons supernatant, retains the second precipitating;The centrifuge tube is covered tightly, in 5 DEG C,
14000r/min is centrifuged 3min, removes supernatant, continues the addition 5mL into the centrifuge tube after standing 20min and goes RNA enzyme and go
The water dissolution of DNA enzymatic second precipitating, uses spectrophotometer measurement RNA solution OD260/OD280 ratio to obtain for 2.1
RNA;
Step 2: reverse transcription prepares cDNA step with embodiment one.
Step 3: real-time fluorescence quantitative PCR reaction solution is prepared with implementation in real-time fluorescence quantitative PCR augmentation detection step
Example one, for PCR amplification standardization program use three-step approach, the reaction condition of the three-step approach PCR amplification standardization program include with
Lower step: the 1st stage: the initial denaturation 2 minutes under conditions of 95 DEG C;The reaction of 2nd stage PCR: under conditions of 95 DEG C, reaction 1
Minute, it under conditions of 55 DEG C, reacts 1 minute, under conditions of 72 DEG C, reacts 1 minute, so carry out 40 circulations;Finally
72 DEG C, annealing in 7 minutes extends.
Step 4: the CLC gene expression amount is calculated:
The amplification curve and melting curve for confirming real-time fluorescence quantitative PCR after reaction, read the Ct of CLC and GAPDH
Value selects △ Ct analytic approach (the Ct value of CLC subtracts the Ct value of GAPDH) to be analyzed, using GAPDH as reference gene;It is positive
Control Ct value<20 and negative control Ct value>38 are considered as experiment effectively, and otherwise experiment is invalid;
Positive control wells are averaged Ct:16.9;Negative control hole is averaged Ct:39.7;Sample CLC is averaged Ct:18.8;Sample
GAPDH is averaged Ct:16.4;Difference value: 18.8-16.4 2.4.Indicate that the patient CLC is expressed as 0.19 times (1/ of GAPDH
22.4)。
Embodiment 6:
The collection and processing of sample:
Patient's normal saline flushing nasal cavity is advised before obtaining cell, with hairbrush (production of Copan company) in nose under nasal endoscopes
Polyp surface presses 30s, rotation 3-4 circle, and hairbrush is placed in lysate by swipe polyp surface, and 4 DEG C of short-term preservations (are no more than
24 hours), or be transferred to lower than -20 DEG C of long-term preservations.
A method of CLC gene expression amount in detection nasal cavity cast-off cells, comprising the following steps:
Step 1: from nasal cavity cast-off cells extract RNA step: to equipped with nasal cavity cast-off cells centrifuge tube in be added
After 0.1mLRNA extract is dissolved, vibrated, it is stored at room temperature 7min;0.03mL chloroform is added, concussion is mixed, is stored at room temperature
7min, in 5 DEG C, 14000r/min is centrifuged 20min;Supernatant 20mL is taken, the isopropanol of 0.015mL is added, is stood after mixing
12min, in 5 DEG C, 14000r/min is centrifuged 20min and abandons supernatant, retains the first precipitating;It is added into first precipitating
The ethyl alcohol of the concentration 90% of 0.0075mL, in 5 DEG C, 14000r/min is centrifuged 3min, abandons supernatant, retains the second precipitating;Cover tightly institute
Centrifuge tube is stated, in 5 DEG C, 14000r/min is centrifuged 3min, removes supernatant, continues to add into the centrifuge tube after standing 20min
Enter 0.01mL to go RNA enzyme and the water of DNA enzymatic is gone to dissolve second precipitating, using spectrophotometer measurement RNA solution OD260/
OD280 ratio is 2.1, obtains RNA;
Step 2: reverse transcription prepares cDNA step with embodiment one.
Step 3: real-time fluorescence quantitative PCR reaction solution is prepared with implementation in real-time fluorescence quantitative PCR augmentation detection step
Example one, for PCR amplification standardization program use three-step approach, the reaction condition of the three-step approach PCR amplification standardization program include with
Lower step: the 1st stage: the initial denaturation 2 minutes under conditions of 95 DEG C;The reaction of 2nd stage PCR: under conditions of 95 DEG C, reaction 1
Minute, it under conditions of 55 DEG C, reacts 1 minute, under conditions of 72 DEG C, reacts 1 minute, so carry out 40 circulations;Finally
72 DEG C, annealing in 7 minutes extends.
Step 4: the CLC gene expression amount is calculated:
The amplification curve and melting curve for confirming real-time fluorescence quantitative PCR after reaction, read the Ct of CLC and GAPDH
Value selects △ Ct analytic approach (the Ct value of CLC subtracts the Ct value of GAPDH) to be analyzed, using GAPDH as reference gene;It is positive
Control Ct value<20 and negative control Ct value>38 are considered as experiment effectively, and otherwise experiment is invalid;
Positive control wells are averaged Ct:15.9;Negative control hole is averaged Ct:38.7;Sample CLC is averaged Ct:23.8;Sample
GAPDH is averaged Ct:16.4;Difference value: 23.8-16.4 7.4.Indicate that the patient CLC is expressed as 0.006 times (1/ of GAPDH
27.4)。
Sequence table
<110>it raises
Wang Chengshuo
Yan Bing
Beijing Otorhinolaryngology Inst.
Capital University Of Medical Sciences Affiliated Beijing Tongren Hospital
<120>method and application of CLC gene expression amount in nasal cavity cast-off cells are detected
<130> CC18K10087CCN
<141> 2018-07-03
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 649
<212> DNA
<213> human
<400> 1
catttaaatt ctgcagctca gagattcaca cagaagtctg gacacaattc agaagagcca 60
cccagaagga gacaacaatg tccctgctac ccgtgccata cacagaggct gcctctttgt 120
ctactggttc tactgtgaca atcaaagggc gaccacttgc ctgtttcttg aatgaaccat 180
atctgcaggt ggatttccac actgagatga aggaggaatc agacattgtc ttccatttcc 240
aagtgtgctt tggtcgtcgt gtggtcatga acagccgtga gtatggggcc tggaagcagc 300
aggtggaatc caagaatatg ccctttcagg atggccaaga atttgaactg agcatctcag 360
tgctgccaga taagtaccag gtaatggtca atggccaatc ctcttacacc tttgaccata 420
gaatcaagcc tgaggctgtg aagatggtgc aagtgtggag agatatctcc ctgaccaaat 480
ttaatgtcag ctatttaaag agataaccag acttcatgtt gccaaggaat ccctgtctct 540
acgtgaactt gggattccaa agccagctaa cagcatgatc ttttctcact tcaatcctta 600
ctcctgctca ttaaaactta atcaaacttc acaaaaaaaa aaaaaaaaa 649
<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence
<400> 2
ctacccgtgc catacacaga 20
<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence
<400> 3
gttcatgacc acacgacgac 20
<210> 4
<211> 22
<212> DNA
<213> Artificial Sequence
<400> 4
ctcctcctgt tcgacagtca gc 22
<210> 5
<211> 21
<212> DNA
<213> Artificial Sequence
<400> 5
cccaatacga ccaaatccgt t 21
Claims (11)
1. a kind of method of CLC gene expression amount in detection nasal cavity cast-off cells, it is characterised in that: the following steps are included: from nose
RNA is extracted in chamber cast-off cells, is cDNA by total serum IgE reverse transcription, using quantitative polyase chain reaction by the CLC gene in cDNA
The specific primer of CLC gene is respectively adopted with reference gene specific primer and reference gene carries out real time fluorescent quantitative
PCR amplification, the testing result based on amplified production calculate CLC gene expression amount.
2. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 1, it is characterised in that: CLC
The upstream primer of gene is as shown in SEQ ID NO:2, and the downstream primer of CLC gene is as shown in SEQ ID NO:3;
The reference gene is GAPDH, and the upstream primer of the reference gene is as shown in SEQ ID NO:4, the downstream primer
As shown in SEQ ID NO:5.
3. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 1, it is characterised in that: institute
It states nasal cavity cast-off cells and is obtained using hairbrush in nasal polyp surface, and will acquire the hairbrush after nasal cavity cast-off cells and be placed in cell and split
It solves in liquid and is saved in 4 DEG C or less.
4. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 1, it is characterised in that: from
The method of RNA is extracted in nasal cavity cast-off cells, comprising the following steps:
Step 1: the nasal cavity cast-off cells are dissolved in 100~2000 μ L cell pyrolysis liquids, and isometric ethyl alcohol is added,
It is added after mixing into RNA purification column, after centrifugal treating, removes filtrate, the RNA purification column is placed in collecting pipe;
Step 2: the first buffer of 300 μ of μ L~700 L, centrifugal treating being added into the RNA purification column obtained in step 1
Afterwards, the first filtrate is removed;Continue that 400 μ of μ L~800 the second buffers of L are added to the RNA purification column, after centrifugal treating, removes
Second filtrate takes RNA purification column through affording RNA.
5. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 4, it is characterised in that: from
The method that RNA is extracted in nasal cavity cast-off cells, it is further comprising the steps of: into the RNA purification column after removing second filtrate
10~100 μ LDNA enzyme reaction solutions are added, after stewing process, the second buffer described in 300 μ of μ L~700 L, centrifugal treating is added
Afterwards, third filtrate is removed, RNA purification column is taken, using spectrophotometer measurement RNA purity, to obtain RNA after eluting;
The preparation method of the DNA enzymatic reaction solution goes the double of RNA enzyme the following steps are included: take DNA enzymatic buffer, recombinant dnase
It steams water and is mixed to get DNA enzymatic reaction solution.
6. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 4, it is characterised in that: from
The method that RNA is extracted in nasal cavity cast-off cells, further comprising the steps of: in the step 1, the nasal cavity cast-off cells are dissolved in
It is first added after in cell pyrolysis liquid into genomic DNA adsorption column and takes filtrate, then isometric ethyl alcohol is added into the filtrate.
7. the method for CLC gene expression amount, special in detection nasal cavity cast-off cells according to any one of claim 4 to 6
Sign is: the method that RNA is extracted from nasal cavity cast-off cells, further comprising the steps of: taking RNA purification column to be eluted to be added and goes
The distilled water or pyrocarbonic acid diethyl ester of RNA hydrolase handle water, after being stored at room temperature, purify through centrifugal treating, the elution RNA
Column obtains RNA using spectrophotometer measurement RNA purity.
8. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 1, it is characterised in that: from
The method of RNA is extracted in nasal cavity cast-off cells, comprising the following steps: be added into the centrifuge tube equipped with nasal cavity cast-off cells
0.1mL~20mLRNA extract dissolved, vibrate after 0.1~0.5 times of chloroform of the RNA extract volume, shake is added
Mixing is swung, is stored at room temperature, the centrifuge tube is centrifuged, supernatant is taken, 0.5~3 times of isopropanol of the chloroform volume is added,
After mixing stand, be centrifuged, abandon supernatant, retain first precipitating, to it is described first precipitating in be added the isopropanol volume 0.5~
The ethyl alcohol of 5 times of concentration 65%~90% mixes, centrifugation after washed, abandons supernatant, retains the second precipitating;Centrifuge tube is covered tightly, then
Secondary centrifugation removes supernatant, continues 0.01~5mL of addition into the centrifuge tube and goes RNA enzyme and go described in the water dissolution of DNA enzymatic
Second precipitating, using spectrophotometer measurement RNA purity, obtains RNA;
The RNA extract be Trizol, RNAiso Blood, RNAiso Plus or other containing phenol, guanidinium isothiocyanate,
The reagent of any one or more of 8-hydroxyquinoline, guanidinium isothiocyanate and beta -mercaptoethanol.
9. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 1, it is characterised in that:
By method that total serum IgE reverse transcription is cDNA the following steps are included: the reverse transcription mixed liquor of 1~3 μ L, 0~10 μ L is taken to go
RNA hydrolase distilled water and the RNA of extraction issue raw reverse transcription reaction 15min in 37 DEG C of temperature conditions, after in 84 DEG C of temperature strips
The inactivation reaction that reverse transcriptase occurs under part, obtains reverse transcription product cDNA;
Real-time fluorescence quantitative PCR amplification the following steps are included:
Step 1: prepare real-time fluorescence quantitative PCR reaction solution: the PCR premix including 1 μ of μ L~25 L, 0 μ of μ L~10 L's is double
Steam machine fluorescence compensation and corrigent of the water polishing total volume water to 10 μ L, 0 μ of μ L~2 L, 0.01~100 μM of CLC gene
Upstream primer, the downstream primer of 0.01~100 μM of CLC gene, the upstream primer of 0.01~100 μM of reference gene,
The downstream primer of 0.01~100 μM of reference gene, the cDNA of 0.01 μ of μ L~5 L;
Step 2: real-time fluorescence quantitative PCR is carried out using two-step method PCR amplification standardization program or three-step approach PCR amplification standardization program
Detection;
Step 3: calculating CLC gene expression amount.
10. the method for CLC gene expression amount in detection nasal cavity cast-off cells according to claim 9, it is characterised in that: institute
The reaction condition of two-step method PCR amplification standardization program is stated the following steps are included: the 1st stage: the initial denaturation 30 under conditions of 95 DEG C
Second;The reaction of 2nd stage PCR: under conditions of 95 DEG C, reacting 15 seconds, under conditions of 60 DEG C, reacts 60 seconds, annealing extends, such as
This carries out 40 circulations;
The reaction condition of the three-step approach PCR amplification standardization program is the following steps are included: the 1st stage: pre- under conditions of 95 DEG C
Denaturation 2 minutes;The reaction of 2nd stage PCR: under conditions of 95 DEG C, reacting 1 minute, under conditions of 55 DEG C, reacts 1 minute,
It under conditions of 72 DEG C, reacts 1 minute, so carries out 40 circulations;Last 72 DEG C, annealing in 7 minutes extends;
The method for calculating the CLC gene expression amount are as follows: calculate Δ CT or 2-ΔΔCTTo calculate the expression quantity of target gene;Wherein
Δ CT=(CT (CLC)-CT (GAPDH)) ,-Δ Δ CT=- (Δ CT (processing sample CT (CLC)-CT (GAPDH))-normal healthy controls
Group average delta CT);The each control group Δ CT of healthy control group average delta CT=∑ (CT (CLC)-CT (GAPDH))/control group sample
This number.
11. the method for CLC gene expression amount is being made in a kind of described in any item detection nasal cavity cast-off cells of claim 1~10
Detection is ready for use on the application in the kit of the chronic nasosinusitis hypotype of nasal polyp.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810719334.2A CN108977510A (en) | 2018-07-03 | 2018-07-03 | Detect the method and application of CLC gene expression amount in nasal cavity cast-off cells |
PCT/CN2019/093299 WO2020007230A1 (en) | 2018-07-03 | 2019-06-27 | Method and kit for detecting chronic sinusitis with subtype of nasal polyp and application of clc gene or protein as biomarker |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810719334.2A CN108977510A (en) | 2018-07-03 | 2018-07-03 | Detect the method and application of CLC gene expression amount in nasal cavity cast-off cells |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108977510A true CN108977510A (en) | 2018-12-11 |
Family
ID=64536849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810719334.2A Pending CN108977510A (en) | 2018-07-03 | 2018-07-03 | Detect the method and application of CLC gene expression amount in nasal cavity cast-off cells |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108977510A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101956014A (en) * | 2010-09-30 | 2011-01-26 | 中山大学 | Kit for detecting 7 genetic markers of peripheral blood in early diagnosis of nasopharyngeal darcinoma |
CN104975071A (en) * | 2014-04-02 | 2015-10-14 | 中山大学附属肿瘤医院 | Molecular marker for diagnosing and treating tumors |
CN106645752A (en) * | 2016-12-27 | 2017-05-10 | 中南大学湘雅医院 | Galectin-10 and application of specific antibody thereof in preparation of kit for detecting nasopharyngeal carcinoma |
-
2018
- 2018-07-03 CN CN201810719334.2A patent/CN108977510A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101956014A (en) * | 2010-09-30 | 2011-01-26 | 中山大学 | Kit for detecting 7 genetic markers of peripheral blood in early diagnosis of nasopharyngeal darcinoma |
CN104975071A (en) * | 2014-04-02 | 2015-10-14 | 中山大学附属肿瘤医院 | Molecular marker for diagnosing and treating tumors |
CN106645752A (en) * | 2016-12-27 | 2017-05-10 | 中南大学湘雅医院 | Galectin-10 and application of specific antibody thereof in preparation of kit for detecting nasopharyngeal carcinoma |
Non-Patent Citations (5)
Title |
---|
CHANG LIU, ET AL.: "Predictive Significance of Charcot–Leyden Crystals for Eosinophilic Chronic Rhinosinusitis With Nasal Polyps", 《AMERICAN JOURNAL OF RHINOLOGY & ALLERGY》 * |
OKADA, NAOKO, ET AL.,: "Distinct and Common Gene Expression Profiles of Nasal Polyp Tissues in Eosinophilic and Non-Eosinophilic Chronic Rhinosinusitis", 《JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY》 * |
T KREJSGAARD, ET AL.,: "Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome", 《LEUKEMIA》 * |
WEIQING WANG, ET AL.,: "Transcriptome analysis reveals distinct gene expression profiles in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps", 《SCIENTIFIC REPORTS》 * |
王威清: "嗜酸与非嗜酸性慢性鼻—鼻窦炎伴鼻息肉的转录组差异分析及功能研究", 《北京协和医学院 中国医学科学院 博士论文》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104450901B (en) | The nucleic acid markers of quick diagnosis mucocutaneous lymphnode syndrome and test kit thereof | |
CN108977511A (en) | Detect the method and application of CST1 gene expression amount in nasal cavity cast-off cells | |
CN104293908A (en) | Serum miRNA maker assemblage for detecting nonalcoholic fatty liver, and its application | |
CN107964563A (en) | A kind of liver cancer detection kit | |
CN112575079B (en) | Exosome miRNA (micro ribonucleic acid) serving as molecular marker for diagnosing type 2 diabetes combined coronary heart disease and application of exosome miRNA | |
Zhang et al. | Extracellular vesicle-derived miR-26b-5p is up-regulated in the serum of patients with diabetic retinopathy | |
CN111944895B (en) | Kit for predicting semen collection fate of non-obstructive azoospermia patient | |
WO2019117257A1 (en) | Method for assisting in detection of breast cancer | |
Guo et al. | Differential expression of urinary exosomal miRNA in idiopathic membranous nephropathy and evaluation of its diagnostic value | |
CN109402262A (en) | The PCR detection kit of auxiliary diagnosis neuroblastoma and the method for detecting miR-199a-3p expression | |
CN105349641A (en) | Acute myocardial infarction related gene SERPINB13 and application thereof | |
CN108913763A (en) | Detect the method and application of SAA2 gene expression amount in nasal cavity cast-off cells | |
CN108913762A (en) | The application of kit and CST1 gene as biomarker for detecting chronic nasosinusitis with nasal polyp hypotype | |
CN108300788A (en) | A kind of micro RNA combination and its application for detecting light-duty brain trauma | |
CN107502664A (en) | A kind of biomarker and kit and purposes for being used to diagnose Kawasaki disease | |
CN108913764A (en) | Detect the method and application of ALOX15 gene expression amount in nasal cavity cast-off cells | |
CN108977510A (en) | Detect the method and application of CLC gene expression amount in nasal cavity cast-off cells | |
CN116516008A (en) | Gastric mucosa intestinal epithelium metaplasia marker JUN and application thereof | |
CN110295228A (en) | Detect application of the substance of GATA2 in preparation diagnostic activities kit lungy | |
CN110244064A (en) | Cystatin SN is predicting the application in sensibility of the chronic nasosinusitis companion's Nasal Polyps Patients to glucocorticoid | |
CN110241199A (en) | MiR-584-5p is as the application in acute respiratory distress syndrome biomarker | |
CN109735612A (en) | The biomolecule marker and its kit of Kawasaki disease coronary aneurysm complication | |
CN108977434A (en) | The extracting method of nasal cavity cast-off cells RNA | |
CN109536502A (en) | A kind of PCR internal reference suitable for Trophoblastic Tumor blood plasma excretion body miRNA | |
CN108707661A (en) | The application of kit and CLC genes as biomarker for detecting chronic nasosinusitis with nasal polyp hypotype |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |